about
EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against CancerNovel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cellsImmunotherapy for ovarian cancer.Rapid optimization of drug combinations for the optimal angiostatic treatment of cancerThe molecular landscape of premenopausal breast cancer.Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.Integrin modulators: a patent review.Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.Therapeutic modulation of prostate cancer metastasis.Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.Proteolytic fragments of fibronectin function as matrikines driving the chemotactic affinity of prostate cancer cells to human bone marrow mesenchymal stromal cells via the α5β1 integrin.Integrins as Therapeutic Targets: Successes and Cancers.Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.Integrin α5 triggers the metastatic potential in renal cell carcinoma.Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma.
P2860
Q27340196-ADF1BE18-B050-44C0-8F76-E088F60416E8Q28829821-BD30F348-6C5F-42C4-AD78-F892A49FD065Q35164189-A7DA7C01-92B6-4042-84F2-D8034AFB21F9Q35757208-5A38AE6A-ECDC-409E-A981-73B4E8CF763EQ35937970-CC741886-F071-46EB-9EC0-399FD5D66468Q38016208-D4172F9B-5C5E-445C-8672-E696246C7C18Q38139612-09E96E38-A66C-4848-8BBD-A70E8CFFF2E0Q38161726-66AE8DAB-1E08-43C9-BD25-9BECD3947898Q38182140-58AE9596-6BB7-419F-B99C-849FC19B6939Q39429469-63D0572C-74F4-4A71-B21C-FAB0BE6FE910Q41510265-1DBF6EE5-EB4D-44A3-B615-BAD353F0B413Q41670949-6603172C-E5DD-4A4D-A6C6-90D236C4B0E8Q44411444-03A1DCDE-61FF-4F93-A339-0F4F30D0B889Q47140682-6FC03DB3-8B35-4EDC-A21C-4AA14F5D195AQ53714956-F43B3EDA-111B-4E6C-973F-4C57783DDF43
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Volociximab in cancer.
@en
Volociximab in cancer.
@nl
type
label
Volociximab in cancer.
@en
Volociximab in cancer.
@nl
prefLabel
Volociximab in cancer.
@en
Volociximab in cancer.
@nl
P2860
P1476
Volociximab in cancer
@en
P2093
Salah Almokadem
P2860
P304
P356
10.1517/14712598.2012.646985
P407
P577
2011-12-22T00:00:00Z